DataLabs, a developer of Web-based software applications for clinical development, has announced that it has acquired Broadpeak LLC, an eClinical collaboration software company that provides applications to the biopharmaceutical and CRO industries to improve the workflow and communication processes in managing clinical trials.
“The rapid adoption of EDC has created a Web-connected user base which is now looking for better tools to manage and collaborate within this new electronic environment. Broadpeak’s software products address these newfound needs and will quickly set the bar for the next generation of clinical trial management and collaboration solutions,” said Nick Richards, DataLabs COO.
According to the announcement, the Broadpeak solution facilitates all internal and external collaboration for study activities, from beginning to end. It accelerates the time for recruiting qualified investigators, initiating each site (including the collection and versioning of regulatory documents), communicating with investigative sites, and providing a central portal in which to manage the progress of each clinical trial.
The Broadpeak solution will be integrated as part of the DataLabsXC eClinical Platform family of products, outlines the report. DataLabsXC Vision is a clinical portal solution providing digital dashboard and reporting capabilities to monitor the key metrics of a clinical trial in near real time. DataLabsXC Workspace is a suite of collaborative solutions to help manage documents, communications and scheduling among those involved in conduct of the clinical trial. Site Manager, the first module offered under the Workspace suite, is a collaborative solution to help coordinate activities involved in setting up and managing investigative sites.
DataLabs believes that the Broadpeak solution will enhance sales of their flagship eCDM product, DataLabsXC Clinical. The Broadpeak solution will be sold as part of the DataLabsXC eClinical Platform or as a stand alone solution.